Search
for
Sort by
Research 961–990 of 1000+
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- 40062 Mini pulse corticosteroid therapy with oral dexamethasone for moderate to severe alopecia areata: a multicentric study
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity
- Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Case report of novel combination of anthralin and calcipotriene leading to trichologic response in alopecia areata
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- The Roles of Exosomes in Regulating Hair Follicle Growth
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Response of alopecia areata of the beard to oral tofacitinib
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience